sciclone pharmaceuticals inc
(SCLN:Consolidated Issue Listed on NASDAQ Global Select )
Friedhelm Blobel Ph.D.
Chief Executive Officer, President, Executive Director and Member of Business Development Committee, SciClone Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 5 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Friedhelm Blobel, Ph.D. has been the Chief Executive Officer and President at SciClone Pharmaceuticals, Inc. since June 2, 2006. Dr. Blobel has more than 20 years experience in the pharmaceutical and healthcare industries. Dr. Blobel served as an Interim Acting Chief Financial Officer of SciClone Pharmaceuticals, Inc. from May 31, 2013 to July 15, 2013. Dr. Blobel served as Acting Chief Financial Officer of SciClone Pharmaceuticals Inc. from May 1, 2008 to December ...
950 Tower LanePhone: 650-358-3456
Foster City, California 94404
Board Members Memberships*
Chief Executive Officer, President and Director
Chief Executive Officer, President, Executive Director and Member of Business Development Committee
|Edward M. Kaye M.D., Ph.D.||Interim Chief Executive Officer, Chief Medical Officer and Senior Vice President|
Sarepta Therapeutics, Inc.
|Arthur P. Bedrosian J.D.||Chief Executive Officer, Director and Chairman of Strategic Planning Committee|
Lannett Company, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|$814.6K||Compensation as of Fiscal Year 2014.|